First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration

NCT02076919 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-Related Macular Degeneration

Interventions

DRUG: LHA510 Ophthalmic Suspension
DRUG: LHA510 Vehicle

Sponsor

Alcon Research